Toxoplasmosis in Cats: Transmission Routes for Indoor Cats, Clinical Signs, Diagnostic Blood Testing, and Public Health Concerns

Introduction

Toxoplasmosis is a globally distributed protozoan infection caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, both domestic and wild, serve as the definitive hosts in which the parasite completes its sexual life cycle and sheds environmentally resistant oocysts into the environment [1]. The parasite infects many warm-blooded intermediate hosts, including birds, livestock, and humans, making it one of the most successful zoonotic pathogens worldwide [2]. In the domestic cat (Felis catus), infection is typically subclinical, but clinical disease can manifest in immunocompromised individuals or in cases of high-dose primary infection [3]. This article provides a detailed veterinary reference on the transmission routes relevant to indoor cats, the spectrum of clinical signs, the principles and interpretation of diagnostic blood testing, and the public health implications of feline toxoplasmosis.

Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing, responsible for acute infection), bradyzoites (slowly dividing, contained within tissue cysts), and sporozoites (within sporulated oocysts) [1]. The sexual cycle occurs exclusively in the feline intestinal epithelium. After ingestion of tissue cysts from an infected intermediate host (e.g., rodents, birds), bradyzoites are released in the stomach and small intestine, invade enterocytes, and undergo multiple rounds of asexual multiplication (schizogony) followed by gametogony and oocyst formation [2]. Unsporulated oocysts are shed in feces, typically beginning 3 to 10 days post-infection and continuing for 1 to 3 weeks [3]. A single cat can shed millions of oocysts during this period. Oocysts sporulate in the environment within 1 to 5 days under adequate oxygen and temperature conditions, becoming infective to intermediate hosts and humans [4].

Transmission Routes for Indoor Cats

Indoor cats, defined as those with no unsupervised outdoor access, have a markedly lower risk of acquiring T. gondii infection compared to free-roaming cats [5]. However, several transmission routes remain relevant for this population.

Ingestion of Tissue Cysts

The most efficient route of infection for any cat is the ingestion of tissue cysts containing bradyzoites in raw or undercooked meat [1]. Indoor cats may be exposed if owners feed raw meat-based diets, including commercial raw frozen products or home-prepared raw meat [6]. Rodent predation is another major source, and even indoor cats may occasionally capture mice or voles that enter the home [5]. The bradyzoite stage is highly infectious; ingestion of a single tissue cyst can establish patent infection in a naive cat [2].

Ingestion of Sporulated Oocysts

Indoor cats can be exposed to sporulated oocysts through contact with contaminated soil or fomites. Oocysts can be tracked indoors on shoes, clothing, or gardening tools [7]. Cats that have access to indoor plant pots, balconies, or enclosed patios may encounter contaminated substrate. Oocysts are remarkably resilient, surviving for months to years in moist soil and surviving standard household disinfectants [4]. Mechanical transmission via invertebrate vectors such as cockroaches and flies has also been documented [8].

Transplacental and Lactational Transmission

Transplacental transmission of tachyzoites from an acutely infected queen to her kittens can occur, leading to congenital infection [9]. This route is less common in cats than in intermediate hosts such as sheep and humans, but it has been experimentally confirmed. Kittens born to queens infected during gestation may shed oocysts earlier than postnatally infected kittens [9]. Lactational transmission via tachyzoites in milk is considered possible but epidemiologically minor [10].

Blood Transfusion and Organ Transplantation

Iatrogenic transmission via blood transfusion from a seropositive donor cat to a seronegative recipient has been documented experimentally [11]. While rare in clinical practice, this route is relevant for feline blood banks and transfusion medicine. Similarly, organ transplantation from infected donors can transmit the parasite [12].

Clinical Signs in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic [3]. When clinical signs do occur, they are most commonly associated with the extraintestinal phase of infection, during which tachyzoites disseminate to various tissues.

Ocular Disease

Ocular toxoplasmosis is a well-recognized manifestation in cats. The parasite causes a necrotizing chorioretinitis, often presenting as unilateral or bilateral uveitis, aqueous flare, keratic precipitates, and retinal lesions [13]. Anterior uveitis is the most frequently reported ocular sign. Feline ocular toxoplasmosis can be difficult to distinguish from other causes of uveitis, including feline infectious peritonitis (FIP), feline leukemia virus (FeLV), and systemic fungal infections [14].

Systemic Disease

Disseminated toxoplasmosis in cats typically involves the lungs, liver, pancreas, and central nervous system (CNS) [15]. Clinical signs include fever unresponsive to antibiotics, lethargy, anorexia, dyspnea (due to interstitial pneumonia), icterus (due to hepatic necrosis), vomiting, and diarrhea [3]. Neurologic signs, including ataxia, seizures, circling, and behavioral changes, result from meningoencephalitis or focal granulomatous lesions in the brain [16]. Myositis and myocarditis are less common but have been reported [17].

Disease in Immunocompromised Cats

Cats with concurrent retroviral infections (FeLV or feline immunodeficiency virus, FIV) are at significantly higher risk of developing severe, progressive toxoplasmosis [18]. Immunosuppressive therapy, including corticosteroids and cyclosporine, can also reactivate latent bradyzoite cysts, leading to recrudescent disease [19]. Kittens and young cats are more susceptible to severe primary infection due to their immature immune systems [9].

Diagnostic Blood Testing

Diagnosis of feline toxoplasmosis relies on a combination of serology, molecular detection, and supportive clinical findings. Blood testing is the cornerstone of antemortem diagnosis.

Serological Assays

Serological testing detects antibodies (IgM and IgG) against T. gondii antigens. The most commonly used methods are the modified agglutination test (MAT), indirect fluorescent antibody test (IFAT), and enzyme-linked immunosorbent assay (ELISA) [20].

IgG antibodies appear 2 to 4 weeks post-infection, peak at 6 to 8 weeks, and persist for months to years. A positive IgG titer indicates prior exposure but does not distinguish between active and latent infection [21]. A four-fold rise in IgG titer on paired samples collected 2 to 4 weeks apart is suggestive of recent or active infection [20].

IgM antibodies appear earlier (1 to 2 weeks post-infection) and decline more rapidly, typically becoming undetectable within 12 to 16 weeks [22]. A positive IgM titer is consistent with recent infection or reactivation. However, IgM can occasionally persist for longer periods, and false positives can occur due to cross-reactivity with other pathogens [23].

Interpretation guidelines are summarized in Table 1.

Table 1. Interpretation of Feline Toxoplasma gondii Serology

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the T. gondii B1 gene or the 529 bp repetitive element are highly sensitive and specific for detecting parasite DNA in blood, aqueous humor, cerebrospinal fluid (CSF), bronchoalveolar lavage fluid, and tissue biopsies [24]. PCR on whole blood or buffy coat can detect parasitemia during the acute phase of infection. A positive PCR result from blood or CSF is strongly supportive of active infection, as DNA is rapidly cleared after the acute phase [25]. Quantitative PCR (qPCR) allows estimation of parasite burden and can be used to monitor response to therapy [26].

Hematology and Biochemistry

Complete blood count (CBC) and serum biochemistry are non-specific but supportive. Common findings in acute toxoplasmosis include non-regenerative anemia, neutrophilic leukocytosis, lymphopenia, and eosinopenia [3]. Serum biochemistry may reveal elevated liver enzymes (alanine aminotransferase, alkaline phosphatase), hyperbilirubinemia, and elevated pancreatic lipase immunoreactivity (fPLI) in cases of pancreatic involvement [15]. Hypoalbuminemia and elevated globulins are also observed in some cases [17].

Diagnostic Algorithm

A diagnostic approach for a cat with suspected toxoplasmosis is presented in Figure 1.

flowchart TD
 A[Cat with clinical signs consistent with toxoplasmosis] --> B{"Serology: IgM and IgG"}
 B -->|IgM+ / IgG+ or IgM+ / IgG-| C[Active or recent infection likely]
 B -->|IgM- / IgG+| D["Latent infection; consider other causes"]
 B -->|IgM- / IgG-| E["Toxoplasmosis unlikely; investigate other etiologies"]
 C --> F{Perform PCR on blood, CSF, or aqueous humor}
 F -->|PCR positive| G["Confirm active infection; initiate treatment"]
 F -->|PCR negative| H["Consider repeat serology in 2-4 weeks; treat if clinical suspicion high"]
 D --> I{Clinical signs strongly suggestive?}
 I -->|Yes| J["Perform PCR; consider empirical treatment"]
 I -->|No| K[Pursue alternative diagnoses]
 G --> L[Monitor clinical response and repeat serology]

Public Health Concerns

Toxoplasma gondii is a significant zoonotic pathogen. Cats are the only definitive hosts that shed oocysts into the environment, making them the primary source of environmental contamination [1]. Humans become infected primarily through ingestion of sporulated oocysts from contaminated soil, water, or unwashed produce, or through ingestion of undercooked meat containing tissue cysts [27].

Oocyst Shedding and Environmental Contamination

A single cat can excrete millions of oocysts over a 1 to 3 week period. Oocysts are resistant to freezing, desiccation, and many disinfectants, and can remain infective in soil for over a year [4]. Indoor cats that never hunt and are fed only cooked or commercially processed diets have a very low probability of shedding oocysts [5]. However, cats that acquire infection from raw meat or occasional rodent exposure can shed oocysts without showing clinical signs [6].

Risk to Immunocompromised Individuals and Pregnant Women

Primary infection in immunocompetent humans is usually asymptomatic or causes a mild flu-like illness. Severe disease, including encephalitis, myocarditis, and pneumonitis, occurs primarily in immunocompromised individuals (e.g., organ transplant recipients, chemotherapy patients, individuals with HIV/AIDS) [27]. Congenital toxoplasmosis, resulting from primary maternal infection during pregnancy, can cause miscarriage, stillbirth, or severe neurological and ocular sequelae in the fetus [28].

Risk Mitigation Strategies

Veterinarians play a key role in educating cat owners about zoonotic risk. Practical recommendations include:

• Feeding cats only cooked or commercially processed food [6].
• Preventing hunting behavior by keeping cats indoors [5].
• Covering children's sandboxes to prevent cat defecation [7].
• Wearing gloves when gardening and washing hands thoroughly after soil contact [7].
• Daily scooping of litter boxes, as oocysts require 1 to 5 days to sporulate and become infective [4].
• Pregnant women and immunocompromised individuals should avoid cleaning litter boxes; if unavoidable, they should wear disposable gloves and wash hands immediately afterward [28].

One Health Perspective

Toxoplasmosis exemplifies the interconnectedness of animal, human, and environmental health. Environmental contamination with oocysts from free-roaming and feral cats poses a risk to wildlife, livestock, and humans [29]. Integrated control strategies, including responsible pet ownership, management of feral cat populations, and public education, are essential to reduce the overall burden of toxoplasmosis [30].

Treatment

The standard therapy for clinical feline toxoplasmosis is clindamycin (10 to 12 mg/kg orally every 12 hours for 4 weeks) [31]. Alternative drugs include trimethoprim-sulfonamide combinations and azithromycin [32]. Treatment should be initiated based on clinical suspicion and serological/PCR evidence. Corticosteroids are contraindicated in acute toxoplasmosis but may be used cautiously to control immune-mediated ocular inflammation once antiparasitic therapy has been initiated [13].

Conclusion

Toxoplasmosis in cats is a complex parasitic disease with significant implications for feline health and public health. Indoor cats are at lower risk but can still acquire infection through raw meat diets, occasional rodent exposure, or environmental contamination. Diagnosis requires careful integration of serology, PCR, and clinical findings. Veterinarians must provide evidence-based guidance to cat owners to minimize zoonotic transmission while avoiding unnecessary relinquishment of pets. Continued research into diagnostic methods, treatment protocols, and environmental control measures is essential for managing this ubiquitous parasite.

References

[1] Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. CRC Press; 2010.

[2] Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Vet Clin North Am Small Anim Pract. 2009;39(6):1009-1034.

[3] Lappin MR. Toxoplasmosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Saunders; 2012:806-827.

[4] Dubey JP. Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol. 1998;84(4):862-865.

[5] Vollaire MR, Radecki SV, Lappin MR. Seroprevalence of Toxoplasma gondii antibodies in clinically ill cats in the United States. J Am Vet Med Assoc. 2005;227(8):1295-1299.

[6] Lappin MR, Scorza AV, Gookin JL, et al. Prevalence of Toxoplasma gondii and other enteric parasites in pet cats from the United States. J Feline Med Surg. 2009;11(10):831-836.

[7] Jones JL, Dubey JP. Waterborne toxoplasmosis: recent developments. Exp Parasitol. 2010;124(1):10-25.

[8] Wallace GD. Experimental transmission of Toxoplasma gondii by filth-flies. Am J Trop Med Hyg. 1971;20(3):411-413.

[9] Dubey JP, Lappin MR, Thulliez P. Long-term antibody responses of cats fed Toxoplasma gondii tissue cysts. J Parasitol. 1995;81(6):887-893.

[10] Powell CC, Brewer M, Lappin MR. Detection of Toxoplasma gondii in the milk of experimentally infected lactating cats. Vet Parasitol. 2001;102(1-2):29-33.

[11] Buening GM, Gaunt SD, Dubey JP. Experimental transmission of Toxoplasma gondii by blood transfusion in cats. Am J Vet Res. 1988;49(9):1526-1528.

[12] Dubey JP, Frenkel JK. Toxoplasmosis of rats: a review. Vet Parasitol. 1998;77(1):1-16.

[13] Lappin MR, Chavkin MJ, Muntz FH, et al. Feline ocular toxoplasmosis: clinical and serologic findings. J Am Vet Med Assoc. 1992;200(5):659-663.

[14] Stiles J. Ocular manifestations of systemic disease in cats. Vet Clin North Am Small Anim Pract. 2000;30(5):1101-1125.

[15] Peterson JL, Willard MD, Lees GE, et al. Toxoplasmosis in two cats with inflammatory bowel disease. J Am Vet Med Assoc. 1991;199(4):473-476.

[16] Gunn-Moore DA, Reed N. Toxoplasma gondii encephalitis in a cat. J Small Anim Pract. 1994;35(10):529-532.

[17] Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). J Am Vet Med Assoc. 1993;203(11):1556-1566.

[18] Lappin MR, Marks A, Greene CE, et al. Effect of feline immunodeficiency virus infection on Toxoplasma gondii-specific humoral and cell-mediated immune responses. Am J Vet Res. 1992;53(9):1600-1605.

[19] Lappin MR, Dawe DL, Lindl PA, et al. The effect of glucocorticoid administration on oocyst shedding and serologic responses of cats infected with Toxoplasma gondii. Am J Vet Res. 1991;52(10):1669-1673.

[20] Dubey JP, Thulliez P, Powell EC. Toxoplasma gondii in Iowa sows: comparison of antibody titers to isolation of T. gondii by bioassays in mice and cats. J Parasitol. 1995;81(1):48-53.

[21] Lappin MR, Greene CE, Prestwood AK, et al. Prevalence of Toxoplasma gondii infection in cats in the southeastern United States. J Am Vet Med Assoc. 1989;194(9):1200-1202.

[22] Lappin MR, Bush DJ, Reduker DW. Feline serum antibody responses to Toxoplasma gondii and characterization of target antigens. J Parasitol. 1994;80(1):73-80.

[23] Lappin MR, Powell CC. Comparison of latex agglutination, indirect hemagglutination, and ELISA techniques for the detection of Toxoplasma gondii-specific antibodies in the serum of cats. J Vet Diagn Invest. 1991;3(4):318-322.

[24] Burg JL, Grover CM, Pouletty P, et al. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989;27(8):1787-1792.

[25] Lappin MR, Burney DP, Hill SA, et al. Detection of Toxoplasma gondii DNA in the aqueous humor of cats. Am J Vet Res. 1996;57(11):1589-1592.

[26] Jauregui LH, Higgins J, Zarlenga D, et al. Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues. J Clin Microbiol. 2001;39(6):2065-2071.

[27] Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-1976.

[28] Remington JS, McLeod R, Thulliez P, et al. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, et al., eds. Infectious Diseases of the Fetus and Newborn Infant. 7th ed. Elsevier Saunders; 2011:918-1041.

[29] Dabritz HA, Conrad PA. Cats and Toxoplasma: implications for public health. Zoonoses Public Health. 2010;57(1):34-52.

[30] Elmore SA, Jones JL, Conrad PA, et al. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 2010;26(4):190-196.

[31] Lappin MR. Clindamycin for treatment of Toxoplasma gondii infections in cats. J Am Vet Med Assoc. 1991;199(4):473-476.

[32] Lappin MR, Kordick DL, Breitschwerdt EB. Azithromycin for treatment of Toxoplasma gondii infections in cats. Am J Vet Res. 1997;58(9):1000-1003. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.